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A disintegrin and metalloprotease 10 (ADAM10) is a ubiqui-
tously expressed transmembrane metalloprotease that cleaves
the extracellular regions from its transmembrane substrates.
ADAM10 is essential for embryonic development and is
implicated in cancer, Alzheimer, and inflammatory diseases.
The tetraspanins are a superfamily of 33 four-transmem-
brane proteins in mammals, of which the TspanC8 subgroup
(Tspan5, 10, 14, 15, 17, and 33) promote ADAM10 intracellular
trafficking and enzymaticmaturation. However, the interaction
between TspanC8s and ADAM10 has only been demonstrated
in overexpression systems and the interaction mechanism
remains undefined. To address these issues, an antibody was
developed to Tspan14, which was used to show co-immunopre-
cipitation of Tspan14 with ADAM10 in primary human cells.
Chimeric Tspan14 constructs demonstrated that the large
extracellular loop of Tspan14 mediated its co-immunoprecipi-
tation with ADAM10, and promoted ADAM10 maturation and
trafficking to the cell surface. Chimeric ADAM10 constructs
showed that membrane-proximal stalk, cysteine-rich, and
disintegrin domains of ADAM10 mediated its co-immunopre-
cipitation with Tspan14 and other TspanC8s. This TspanC8-
interacting region was required for ADAM10 exit from
the endoplasmic reticulum. Truncated ADAM10 constructs
revealed differential TspanC8 binding requirements for the
stalk, cysteine-rich, and disintegrin domains. Moreover, Tspan15
was the only TspanC8 to promote cleavage of the ADAM10
substrate N-cadherin, whereas Tspan14 was unique in reduc-
ing cleavage of the platelet collagen receptor GPVI. These
findings suggest that ADAM10may adopt distinct conforma-
tions in complex with different TspanC8s, which could
impact on substrate selectivity. Furthermore, this study iden-
tifies regions of TspanC8s and ADAM10 for potential inter-
action-disrupting therapeutic targeting.
A disintegrin andmetalloproteases (ADAMs)2 are one of the
major classes of proteases that regulate transmembrane protein
function, turnover and signaling (1, 2). ADAM10, and its most
closely related family member ADAM17/TACE, are trans-
membrane zinc-dependent metalloproteases that contain an
extracellular pro-domain, metalloprotease, disintegrin, and
cysteine-rich and stalk domain, followed by a transmembrane
region and C-terminal cytoplasmic domain. ADAM10 is ubiq-
uitously expressed and has over 40 transmembrane protein
substrates, which it cleaves within the extracellular region to
release this region from the remaining transmembrane frag-
ment. Important substrates forADAM10 are theNotch cell fate
regulators, as demonstrated by the embryonic lethality of
ADAM10/mice at e9.5, which phenocopies the Notch1/
phenotype (3). Other substrates include the amyloid precursor
protein (APP), the IgE receptor CD23, EGF receptor ligands
betacellulin and EGF, the platelet-activating collagen receptor
GPVI, cadherins, and transmembrane chemokines (1, 2, 4, 5).
As a result ADAM10has been implicated as a potential target of
modulation in diseases ranging fromAlzheimer disease to heart
disease and thrombosis to inflammation and cancer (1, 6, 7). Yet
the regulation of ADAM10 itself and protein interactants that
control ADAM10 activation and localization are only begin-
ning to be characterized.
Three independent groups recently identified the TspanC8
subfamily of tetraspanin proteins as regulators of ADAM10
trafficking and maturation in multiple cell types and species
(8–10). Tetraspanins are an evolutionarily conserved family of
proteins, with 33 members in mammals, which contain four
transmembrane spanning regions with two extracellular loops,
one intracellular loop and intracellular N- and C-terminal tails.
Tetraspanins interact with specific partner proteins and can
form tetraspanin-enriched microdomains via tetraspanin-tet-
raspanin interactions. Tetraspanins regulate important aspects
of partner protein function, in particular intracellular traffick-
ing and lateral mobility and clustering at the plasmamembrane
(11, 12). The TspanC8 subgroup of tetraspanins consists of
Tspan5, 10, 14, 15, 17, and 33 (8, 10). The TspanC8s promote
ADAM10maturation, which is the process bywhich the prodo-
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main is cleaved by proprotein convertases during biosynthesis,
and are required for ADAM10 exit from the endoplasmic retic-
ulum (ER) and trafficking to the cell surface (8–10). There is
evidence that different TspanC8s might promote ADAM10
shedding of specific substrates, since Tspan5, Tspan10, and
Tspan14 are regulators of ADAM10-dependent Notch signal-
ing, but Tspan15 is not (10, 13). This theory is supported by
distinct TspanC8 subcellular localizations (10). This suggests
that future therapeutic targeting to disrupt specific TspanC8-
ADAM10 complexes might allow substrate- or cell type-spe-
cificADAM10 targeting, whileminimizing the toxic side effects
that would result from global ADAM10 inhibition. However,
the interacting regions of the TspanC8s and ADAM10 are not
known, therefore such an approach cannot yet be undertaken.
The major aim of this study was to identify the regions of
ADAM10 and TspanC8 proteins that are required to mediate
their interaction. We identify these as the extracellular region
of ADAM10 encompassing the cysteine-rich and stalk regions,
and the large extracellular loops (LELs) of the TspanC8s. How-
ever, we present evidence that different TspanC8s interact with
ADAM10 by distinctmechanisms.Moreover, we show that dif-
ferent TspanC8s can differentially affect cleavage of ADAM10
substrates.
Experimental Procedures
Antibodies—For Western blotting immunoprecipitation
and immunofluorescence microscopy, primary antibodies
were mouse anti-FLAG (M2) and rabbit anti-FLAG (Sigma),
rabbit anti-HA (Cell Signaling Technologies (CST)), mouse
anti-Myc (9B11) and rabbit anti-Myc (CST), mouse anti-
human ADAM10, and goat anti-mouse ADAM10 (R&D Sys-
tems), mouse anti-CD9 (C9-BB) (14), mouse anti-human
N-cadherin (BD Biosciences), rabbit anti-GFP (ab290), and
mouse anti-human calnexin (AF18) (Abcam). The new goat
anti-Tspan14 polyclonal was generated by Everest Biotech
against a C-terminal cytoplasmic region of Tspan14 (SDIEAV-
KAGHH) that is identical between human and mouse.
Expression Constructs—N-terminal FLAG-tagged tetraspa-
nin constructs were produced using the pEF6/Myc-His vector
(Invitrogen) with an N-terminal FLAG tag (15), and cDNAs
were cloned with stop codons to prevent C-terminal Myc-His
tagging as described previously (8). The human FLAG-tagged
Tspan14-CD9 chimera series of constructs were made by a
two-step PCR method using overlapping PCR products as the
second PCR template (16). For Tspan14, the LEL was amino
acids 114–232 and the variable (Var) region 153–221, and for
CD9, the LEL region was 112–192 and the Var region 152–181.
The C-terminal HA-tagged mouse ADAM10 and ADAM17 in
pcDNA3.1 (Invitrogen) have been described previously (17).
Further chimeras of these constructs weremade using the two-
step PCR method described above. The ADAM10 disintegrin
region consisted of amino acids 458–552, the cysteine-rich
region 553–647, and the stalk region 648–673. ADAM17 dis-
integrin region was defined as amino acids 475–563, the cys-
teine-rich region 564–642, and the stalk region 643–671. The
C-terminal Myc-tagged human ADAM10 in pRK5M was from
Addgene (18). The truncated humanADAM10 constructswere
generated by PCR and cloned into the pDisplay vector, which
includes HA- and Myc-tag epitopes (Invitrogen). The human
FcR and C-terminal GFP-tagged human GPVI constructs
were as described (19).
Cell Culture and Transfections—The human embryonic kid-
ney (HEK)-293T (HEK-293 cells expressing the large T-antigen
of simian virus 40) and human HeLa epithelial cell lines were
cultured in complete DMEM (cDMEM) medium (Sigma) that
contains 10% fetal calf serum (Gibco), 4 mM L-glutamine, 100
units/ml penicillin, and 100 g/ml streptomycin (PAA). Tran-
sient transfections in HEK-293T cells were carried out using
polyethylenimine (Sigma) as described (20, 21). ForN-cadherin
and GPVI shedding experiments, 10 M DAPT -secretase
inhibitor and 10 M GI254023X ADAM10 inhibitor (Sigma)
were added 3 h post-transfection. For HeLa cell transfections, 2
g of plasmid DNA was incubated in 250 l of OptiMEM
(Gibco) while 10 l of Lipofectamine 2000 (Invitrogen) was
incubated in 250 l OptiMEM for 7 min before mixing and
incubating for 25min. The Lipofectamine-DNAmixwas added
to 4 105 HeLa cells in 1.5ml of cDMEM for 3 h before replac-
ing the Lipofectamine-DNA mix for cDMEM. Human umbili-
cal vein endothelial cells (HUVECs) were isolated and cul-
tured as described previously (22), using umbilical cords
with consent from the Birmingham Women’s Health Care
NHS Trust and approved by the Ethics Committee at the Uni-
versity of Birmingham.
Platelet Preparation—Human and mouse washed platelets
were isolated fromwhole blood as previously described (23, 24).
Consent for human blood was obtained from each donor, and
platelet preparation was carried out with ethical approval.
Western Blotting and Co-immunoprecipitation—Experi-
ments using primary cells were conducted using the following
numbers of cells: 4 108 human platelets per immunoprecipi-
tation and 1 107 per lane of whole cell lysate; 1.6 108mouse
platelets per immunoprecipitation and 4  106 per whole cell
lysate; and 2.2  106 HUVECs per immunoprecipitation and
5.5  104 per whole cell lysate. Whole cell protein lysates and
co-immunoprecipitation experiments were performed as pre-
viously described (8). Briefly, cells were lysed in 1% digitonin
lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 0.02% NaN3).
Proteins were immunoprecipitated with primary antibody (as
indicated in text) bound to protein G-Sepharose beads for 90
min and washed in 0.1% digitonin lysis buffer. Standard proto-
cols were used for Western blotting and SDS-PAGE. Primary
antibodies were used as indicated in the text with correspond-
ing horseradish peroxide (Pierce) or IRDye 680RD or 800CW
(LI-CORBiosciences)-conjugated secondary antibodies.Mem-
braneswere visualized using Pierce ECLWestern blot substrate
(Thermo Scientific) and exposure to film or using an Odyssey
Infrared Imager (LI-COR Biosciences). All quantitation was
performed using an Odyssey Infrared Imager (LI-COR Biosci-
ences); background signal was removed, and individual band
intensities were compared.
FlowCytometry—For staining ofADAM10, transfectedHeLa
cells were scraped off the plate, and 5  105 cells were stained
with 10 g/ml mouse anti-human ADAM10-APC or isotype
control mouse IgG2b-APC (R&D Systems), and data were col-
lected using CellQuest and a FACSCalibur (BD Biosciences).
The geometric mean fluorescence intensity of isotype control
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staining was subtracted from the human ADAM10 staining to
calculate ADAM10 expression.
Immunofluorescence Microscopy—Transfected HeLa cells
were fixed, washed and blocked as described (22), prior to stain-
ing with primary antibodies. Subsequent staining was with
wheat germ agglutinin (WGA)-FITC (Sigma) and/or secondary
antibodies conjugated toAlexa488, Alexa568, or Alexa647 (Life
Technologies). Images were captured on a Zeiss LSM 710 con-
focal microscope using a 40 objective.
Cell Surface Biotinylation—HEK-293T cells transfected
with HA-tagged ADAM10 constructs were cell surface bioti-
nylated as previously described (8). Cells were lysed in 1%
Triton X-100 lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1
mM EDTA, and 0.02% NaN3) containing protease inhibitors
(Sigma), and anti-HA immunoprecipitates were analyzed by
IRDye 800CW-conjugated neutravidin (LI-COR Biosciences)
Western blotting.
Statistics and Data Analysis—Relative or percentage data
were log transformed and analyzed using a one-way ANOVA
with aDunnett’smultiple comparison testusingGraphPadPrism
software. For comparison of different TspanC8 interactions with
ADAM10 comprising the disintegrin, cysteine-rich domain, and
stalk (DCS),ADAM10CSandADAM10S (Fig. 10A), theTspan14
co-immunoprecipitation with ADAM10DCS was first arbi-
trarily set to 100, and relative Tspan14 co-immunoprecipita-
tions with ADAM10CS and ADAM10S were calculated, based
on data from Fig. 8. Secondly, co-immunoprecipitations of the
other TspanC8s with the three ADAM10 constructs were cal-
culated relative to Tspan14, using data from Fig. 9.
Results
Generation of a New Tspan14 Antibody to Show That
Tspan14 Interacts with ADAM10 in Primary Endothelial Cells
and Platelets—Previous data from our group and other groups
demonstrated that the TspanC8 subfamily of tetraspanins
interact with ADAM10 and are important for the maturation
and cell surface expression ofADAM10 (8–10).However, these
studies used co-immunoprecipitation of epitope-tagged pro-
teins that were overexpressed in cell lines. To confirm that a
TspanC8 can interact withADAM10 at endogenous expression
levels, we generated a polyclonal antibody to the C-terminal
cytoplasmic tail of human Tspan14. Tspan14 was chosen as a
model TspanC8 because we had previously shown this tetras-
panin to regulateADAM10 in primary endothelial cells (8). The
FIGURE 1. Endogenous ADAM10 and Tspan14 interact in platelets and primary endothelial cells. A, HEK-293T cells were mock transfected () or
transfected with a FLAG-tagged human Tspan14 expression construct (). The cells were lysed in 1% Triton X-100 lysis buffer and subjected to anti-Tspan14
(top panel) and anti-FLAG (lower panel) Western blotting. The Tspan14 antibody was raised in goat against a C-terminal cytoplasmic peptide, in collaboration
with Everest Biotech. B, washed human platelets; C, washed mouse platelets and D, human umbilical vein endothelial cells were lysed in 1% digitonin lysis
buffer, and proteins were immunoprecipitatedwith an antibody against ADAM10 or an isotype-matched control. Precipitates were then run on non-reducing
gels, Western blotted, and probedwith Tspan14 (top panels), ADAM10 (middle panels), and CD9 (lower panels) antibodies. Arrows indicate the positions of the
predominant mature form of ADAM10 (A10) and the signal from the immunoprecipitating antibodies (IgG).
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antibody was first validated on FLAG-tagged human Tspan14
expressed in HEK-293T cells. Western blotting of whole cell
lysateswith the anti-Tspan14 antibody detected bands at 25–30
kDa for the FLAG-Tspan14 but not control transfections (Fig.
1A, upper panel). This correlated with bands detected by the
anti-FLAG antibody (Fig. 1A, lower panel), confirming that the
antibody detects Tspan14.
To test whether Tspan14 interacts withADAM10 in primary
cells, platelets and endothelial cells were chosen because
Tspan14 is expressed in these cell types (8, 25, 26). Human
platelets, mouse platelets, and human umbilical vein endothe-
lial cells (HUVECs) were lysed in 1% digitonin lysis buffer,
which we used previously to demonstrate ADAM10-TspanC8
interactions in transfected cells (8). ADAM10 or isotype con-
trol immunoprecipitates and cell lysate were then Western
blotted with antibodies against ADAM10, Tspan14 or CD9, the
latter as a non-TspanC8 control tetraspanin (Fig. 1, B–D). For
each cell type, the Tspan14 antibody detected bands at 25–30
kDa from the ADAM10 immunoprecipitate, but this was
absent from the control immunoprecipitate (Fig. 1, B–D, top
panels). The 25–30 kDa size range is likely due to differential
glycosylation of the single N-linked glycosylation site on
Tspan14, as we have shown for another tetraspanin (15).
Tspan14 was not detected in whole cell lysates, possibly
because Tspan14 is expressed at relatively low levels. ADAM10
expression was confirmed in each ADAM10 immunoprecipi-
tate (Fig. 1, B–D, middle panels). CD9 was undetectable in
ADAM10 immunoprecipitates but was clearly observed in
whole cell lysates (Fig. 1, B–D, lower panels), confirming the
specificity of the ADAM10-Tspan14 interaction. These data
are the first to show an endogenous ADAM10 interaction with
a TspanC8 tetraspanin using specific antibodies.
The Large Extracellular Loop (LEL) of Tspan14 Is Required to
Interact with ADAM10—To determine the region of Tspan14
required for interaction with ADAM10, four FLAG-tagged
human Tspan14 and CD9 chimeras were made (Fig. 2A); CD9
was chosen as a representative non-TspanC8 tetraspanin.
These chimeras involved exchange of the entire LELs, or
exchange of the so-called variable regions of the LEL that are
relatively divergent in sequence, since these have been impli-
cated inmediating interactions between other tetraspanins and
their partners (27). These FLAG-tagged chimeric tetraspanins
were then co-expressed with Myc-tagged human ADAM10 in
HEK-293T cells. Cells were lysed using 1% digitonin lysis
buffer, tetraspanins were immunoprecipitated with an anti-
FLAG antibody, and immunoprecipitates were separated by
SDS-PAGE and probed with anti-Myc and anti-FLAG antibod-
ies to detect ADAM10 and tetraspanins, respectively. The only
chimera that co-immunoprecipitated with ADAM10 com-
prised of CD9with the Tspan14 LEL (Fig. 2B, upper panel), and
this interaction was significant but with a substantially lower
efficiency than wild-type Tspan14 (Fig. 2C). In addition, this
was the only chimera that promoted ADAM10 maturation, as
detected by anti-Myc blotting of whole cell lysates (Fig. 2, B,
middle panel, and D). Similar levels of immunoprecipitation
were achieved for each of the chimeras, as detected by anti-
FLAG blotting of the immunoprecipitates (Fig. 2B, lower
panel). These data suggest that, in the context of chimeric tet-
raspanins, the LEL of Tspan14 is necessary and sufficient to
interact with ADAM10 and promote its maturation, whereas
the variable region of the LEL is also necessary but not
sufficient.
Dornier et al. demonstrated that Tspan14 over-expression is
able to increase the surface expression of ADAM10 in theHeLa
cell line (10). To investigate whether these CD9-Tspan14 chi-
meras can increase cell surface expression of endogenous
ADAM10 in HeLa cells, each chimera was co-expressed with
GFP, to label the transfected cells, and flow cytometry was used
to determine surface expression of ADAM10. Consistent with
the interaction and maturation data in Fig. 2, only the CD9-
Tspan14 LEL chimera and wild-type Tspan14 significantly ele-
FIGURE 2. The large extracellular loop (LEL) of Tspan14 is the region that
interacts with ADAM10 and is required for ADAM10maturation. A, sche-
matic of Tspan14 and CD9 chimeras. The large extracellular loop (LEL) and
variable (var) regionofCD9 (black) andTspan14 (gray)were interchanged; the
N-linked glycosylation site of Tspan14 is indicated by a filled oval. B, HEK-293T
cells were mock transfected () or transfected with expression constructs
containing the FLAG-tagged human tetraspanin chimeras with Myc-tagged
human ADAM10 (). Cell lysates were produced using 1% digitonin lysis
buffer and immunoprecipitatedwith ananti-FLAGantibody. Immunoprecipi-
tated proteins were blotted with anti-Myc tag antibody (top panel) or anti-
FLAG antibody (lower panel). Whole cell lysates were probed with the anti-
Myc tag antibody (middle panel). Data are representative of three
independent experiments. C, quantitation of immunoprecipitated ADAM10.
Data in panel B (upper panel) were quantitated using the Odyssey Infrared
Imaging System (LI-COR), and the amount of ADAM10 immunoprecipitated
was shown relative to immunoprecipitated Tspan14,whichwas arbitrarily set
at 100. Datawere normalized by log transformation and statistically analyzed
using a one-way ANOVA with a Dunnett’s multiple comparison test com-
paredwith themock (****, p 0.0001). Error bars represent standard error of
the mean from three experiments. D, data in panel B (middle panel) were
quantitated, the percentage of mature ADAM10 calculated, and the data log
transformed and statistically analyzed as described for panel C (***, p 
0.001).
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vatedADAM10 surface expression (Fig. 3,A andB). To confirm
that each of these chimeras had access to ADAM10 and were
not simply localized to a different subcellular compartment,
co-immunofluorescence confocal microscopy was performed
in transfected HeLa cells. Some co-localization between each
chimera and ADAM10 was observed (Fig. 4), even for those
which did not co-immunoprecipitate with ADAM10 or pro-
mote its maturation or cell surface expression. Together these
data provide evidence that the LEL of Tspan14 mediates the
interaction with ADAM10 to promote its maturation and traf-
ficking to the cell surface.
The Combined Disintegrin, Cysteine-rich, and Stalk Regions
of ADAM10 Can Mediate the Interaction with TspanC8s—
Having determined that the LEL region of Tspan14 inter-
acted with ADAM10, we focused on the membrane-proximal
extracellular domains of ADAM10, namely the disintegrin (D),
cysteine-rich (C), and stalk (S) domains, as the regions poten-
tially involved in Tspan14 binding. Again a chimeric approach
was employed, using the ADAM10-related ADAM17 (Fig.
5A). HA-taggedmouse ADAM10-ADAM17 chimeras were co-
expressed in HEK-293T cells with or without FLAG tagged
mouse Tspan14, the cells lysed in 1% digitonin and subjected to
anti-FLAG immunoprecipitation. The chimera comprising
ADAM17 with the ADAM10 DCS region co-immunoprecipi-
tated with Tspan14, but the chimera of ADAM10 with the
ADAM17 DCS region did not (Fig. 5B). As controls, ADAM10
co-immunoprecipitated with Tspan14 but ADAM17 did not
(Fig. 5B). This suggests that the region ofADAM10 encompass-
ing the disintegrin, cysteine-rich, and stalk region is necessary
and sufficient to interact with Tspan14. To determine whether
any of these regions alone were sufficient for the interaction,
further chimeras were generated of ADAM17 containing each
of the three individual ADAM10 domains. However, none of
these individual ADAM10 extracellular domains enabled inter-
action with Tspan14 in the ADAM17 backbone (Fig. 5, C and
D). It is possible that some of these chimeras might not be
folded correctly. Nevertheless, the data suggest that the entire
disintegrin, cysteine-rich and stalk region may be important to
mediate the ADAM10-Tspan14 interaction.
As all TspanC8s interact with ADAM10, we sought to exam-
ine whether each TspanC8 behaved similarly to Tspan14 by
interacting with the region of ADAM10 comprising the disin-
tegrin, cysteine-rich domain and stalk. Each of the FLAG-
tagged mouse TspanC8 family members, or CD9 as a control,
was expressed in HEK-293T cells with the ADAM17 10DCS
chimera. Anti-FLAG immunoprecipitationswere performed as
described above. All six of the TspanC8 family members signif-
icantly interactedwith theADAM17 10DCS chimera, but there
were differences in the efficiency of the interactions (Fig. 6, A
andB). In particular, the interactionswithTspan10 and 15were
FIGURE 3. The large extracellular loop (LEL) of Tspan14 is critical for its
ability to increase ADAM10 cell surface accumulation. A, HeLa cells
were transfected with the indicated Tspan14-CD9 chimeras (see Fig. 2A)
and GFP to identify transfected cells. Cells were stained with an APC-
conjugated ADAM10 antibody and analyzed by flow cytometry. Dot plots
are representative of three independent experiments. The bottom left
panel shows isotope control staining. B, average geometric mean fluores-
cent intensities for ADAM10 staining, gated on live and GFP-positive cells,
were compared statistically using a one-way ANOVA with a Dunnett’s
multiple comparison test, compared with the CD9 control (***, p 0.001;
**, p  0.01). Error bars represent standard error of the mean from three
experiments.
FIGURE4.All Tspan14-CD9 chimeras partially co-localizewithADAM10
and so have access to the metalloprotease. HeLa cells were transfected
with the indicated Tspan14-CD9 chimeras (see Fig. 2A) and HA-tagged
mouse ADAM10. Cells were fixed and stained with an anti-HA antibody
(green) and an anti-FLAG antibody (red). Confocal microscopy images are
representative of three independent experiments and at least 15 fields of
view.
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substantially stronger than for other TspanC8s (Fig. 6B). This is
in contrast to the similar levels of interaction previously
observed for each TspanC8 with wild-type ADAM10 (8).
Tspan5, and to a lesser extent Tspan14 and 17, consistently
resulted in higher expression levels of the ADAM17 10DCS
chimera in whole cell lysates (Fig. 6,A and C). It is possible that
these TspanC8s can promote the stability of this chimera.
Together these data suggest that different TspanC8s might
bind toADAM10 via subtly differentmechanisms, and that this
can be revealed by co-immunoprecipitation with the ADAM17
10 DCS chimera.
To investigate how an inability to interact with TspanC8s
impacts ADAM10, the HA-tagged ADAM10 17DCS chimera
was transfected into HeLa cells in the presence or absence of
FLAG-tagged Tspan14. Immunofluorescence confocal micros-
copy showed a perinuclear localization for the ADAM10
17DCS chimera, which did not appear to colocalize with
Tspan14 (Fig. 7A). In contrast, wild-type ADAM10 was not
restricted to the perinuclear region when co-expressed with
Tspan14 and strongly co-localized with Tspan14 (Fig. 7A).
Co-staining with an anti-calnexin antibody, to label the ER
(images not shown), revealed that the ADAM10 17DCS chi-
mera was largely ER-restricted in the presence of Tspan14,
unlike wild-type ADAM10 (Fig. 7B). To confirm that inter-
action with TspanC8s is necessary for ADAM10 cell surface
expression, a cell surface biotinylation approach was used
with transfected HEK-293T cells. No biotinylation of the
ADAM10 17DCS chimera was detected, in contrast to wild-
type ADAM10 (Fig. 7C). These data show that interaction
with a TspanC8 is required for ADAM10 to exit the ER and
thus for normal ADAM10 function, consistent with previous
studies showing that TspanC8s are required for ADAM10
ER exit (9, 10).
The Combined Cysteine-rich and Stalk Regions of ADAM10
Mediate the Interaction with Tspan14—To further isolate the
region of ADAM10 with which Tspan14 interacts, truncations
of the human ADAM10 DCS region were expressed using the
pDisplay expression vector. This utilizes the murine Ig -chain
leader sequence to display the intended protein at the cell sur-
face with HA and Myc tags, fused to the transmembrane
domain of platelet derived growth factor receptor. Using trans-
fected HEK-293T cells and anti-FLAG tetraspanin immuno-
FIGURE 5. The region of ADAM10 comprising the disintegrin domain (D), the cysteine-rich (C), and stalk (S) regions mediates the interaction with
Tspan14. A, schematic of ADAM10 and ADAM17 chimeras. The extracellular disintegrin (D), cysteine-rich (C), and stalk (S) regions of ADAM10 (black) and
ADAM17 (gray) were interchanged together (DCS) or individually. B, HEK-293T cells were mock transfected () or transfected with FLAG-tagged mouse
Tspan14 () in addition to either HA-taggedmouse ADAM10, ADAM17, ADAM17 10DCS, or ADAM10 17DCS. Cells were lysed in 1% digitonin lysis buffer and
immunoprecipitated with an anti-FLAG antibody. Immunoprecipitated proteins were blotted with anti-HA tag antibody (top panel) or anti-FLAG antibody
(lower panel). Whole cell lysates were probed with the anti-HA tag antibody (middle panel). The blots are representative of three independent experiments. C,
HEK-293T cells were co-transfectedwith () or without () FLAG-taggedmouse Tspan14 and either HA-mouse ADAM10, ADAM17, ADAM17 10DCS, ADAM17
10D, ADAM17 10C, or ADAM17 10S. Cells were treated as in B. D, data from panels B and C were quantitated and presented as the relative amount of each
ADAM10/17 construct immunoprecipitated with Tspan14, having arbitrarily set wild-type ADAM10 to 100. Data were normalized by log transformation and
statistically analyzedusing aone-wayANOVAwith aDunnett’smultiple comparison test, comparedwith theADAM17 control (*,p 0.05). Error bars represent
standard errors of the mean from 3–6 experiments.
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precipitations as described previously, comparable levels of co-
immunoprecipitation were observed for ADAM10 wild-type,
DCS or CS truncation constructs with Tspan14 (Fig. 8, A and
B). However, truncation down to just the ADAM10 stalk sub-
stantially reduced the ability of Tspan14 co-immunoprecipitate
with ADAM10 (Fig. 8, C and D). As controls in each of these
experiments, no ADAM10 was detected in immunoprecipita-
tions from CD9 or mock co-transfections (Fig. 8, A–D). The
increase in Tspan14 molecular weight when co-expressed with
ADAM10 CS or S truncation constructs was consistent (Fig. 8,
A and C and data not shown), and is likely due to differential
glycosylation of its single N-linked site. Together these data
suggest that the minimal extracellular regions of ADAM10
required for substantial binding to Tspan14 are the cysteine-
rich domain and stalk.
The TspanC8 Subfamily Proteins Bind Differentially to the
Disintegrin, Cysteine-rich, and Stalk Regions of ADAM10—To
determine whether, like Tspan14, each of the other TspanC8
subfamily members require the ADAM10 cysteine-rich and
stalk regions for minimal binding, they were compared with
Tspan14 for co-immunoprecipitation with each truncated
FIGURE 6. All TspanC8s interact with the region of ADAM10 comprising
the disintegrin (D), cysteine-rich domain (C), and stalk (S). A, HEK-293T
cells were transfected with expression constructs for the HA-tagged mouse
ADAM17 10DCS chimera and FLAG-tagged mouse TspanC8s, CD9 or nega-
tive control (). Lysates were extracted in 1% digitonin lysis buffer and pro-
teins immunoprecipitated with an anti-FLAG antibody. Immunoprecipitates
were blotted with anti-HA tag antibody (top panel) or anti-FLAG antibody
(lower panel). Whole cell lysates were probed with the anti-HA tag antibody
(middle panel). B, data in panel A (upper panel) were quantitated, and the
amount of ADAM17 10DCS immunoprecipitated was normalized for the
amount in the whole cell lysate. Data are shown relative to immunoprecipi-
tated Tspan14, which was arbitrarily set at 100. Data were normalized by log
transformationand statistically analyzedusingaone-wayANOVAwith aDun-
nett’s multiple comparison test compared with the mock. All TspanC8s
bound significantly toADAM1710DCS (p0.0001). Errorbars represent stan-
dard error of themean from three experiments. C, ADAM17 10DCSwhole cell
lysate data in panel A were quantitated, and the amount of ADAM17 10DCS
expressed was normalized to the expression in the first lane, which was arbi-
trarily set at 100. Error bars represent standard error of the mean from three
experiments.
FIGURE 7. The disintegrin (D), cysteine-rich (C), and stalk (S) regions of
ADAM10 are essential for Tspan14-mediated exit from the ER. A, HeLa
cells were transfected with combinations of FLAG-tagged Tspan14 and HA-
tagged mouse ADAM10 wild-type or ADAM10 17DCS. Cells were fixed and
stained with an anti-HA antibody (green), an anti-FLAG antibody (red) and
WGA to visualize the plasma membrane and internal cellular structures by
confocal microscopy. B, HeLa cells were transfected and stained as in panel A
exceptananti-calnexinantibodywasused insteadofWGAtodefinethe limitsof
the ER (images not shown). The HA signal was quantitated across thewhole cell
and within the mask of the calnexin staining, and presented as a percentage of
HA-ADAM10orHA-ADAM1017DCSsignal localized in theER.Dataare represen-
tativeof three independentexperimentsandat least15 fieldsofview.A two-way
ANOVA statistical analysis was performedwith a Bonferroni’s multiple compari-
sonstest (ns,non-significant, ****,p0.0001).C,HEK-293Tcellsweremocktrans-
fected (), or transfectedwithHA-taggedmouseADAM10wild-typeorADAM10
17DCS. Cells were surface biotinylated, lysed, and immunoprecipitated with an
anti-HAantibody. Immunoprecipitateswere stainedwithneutravidin (toppanel)
or an anti-HA antibody (bottom panel). Whole cell lysates were stained with an
anti-HA antibody (middle panel).
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ADAM10 construct. All TspanC8s co-immunoprecipitated
with the ADAM10 DCS truncation (Fig. 9, A and B). Similarly,
all TspanC8s interacted with the CS truncation of ADAM10
(Fig. 9, C andD). Finally, only Tspan15 interacted substantially
with the S truncation representing just the stalk region of
ADAM10 (Fig. 9, E and F). Tspan10, 14, and 17 each interacted
weakly but significantly with the stalk region, while Tspan5 and
33 did not interact at all (Fig. 9, E and F).
To enable a direct comparison of TspanC8 interactions with
the different ADAM10 truncation mutants, the quantitated
data in Figs. 8 and 9 were combined and adjusted to make all
values relative (Fig. 10A). This analysis mitigated differences in
expression between the TspanC8s by directly comparing each
TspanC8 with itself, for the different ADAM10 truncations.
Tspan15 bound equally to each of the ADAM10 truncations,
indicating that the major contact site for Tspan15 is within the
ADAM10 stalk region (Fig. 10A). For all otherTspanC8s, loss of
the cysteine-rich region significantly reduced the interaction
with ADAM10 (Fig. 10A). Furthermore, the Tspan17 interac-
tion with the stalk and cysteine-rich regionwas inhibited by the
presence of the disintegrin domain (Fig. 10A). These findings,
represented in diagrammatic form in Fig. 10B, suggest that the
sixTspanC8s have key differences in theirmechanisms of inter-
action with the region of ADAM10 encompassing the disinteg-
rin, cysteine-rich, and stalk regions.
Differential Effects of TspanC8s on ADAM10 Substrate
Cleavage: Tspan15 Promotes Cleavage of N-cadherin and
Tspan14 Reduces Cleavage of GPVI—To assess whether the
TspanC8s also have differential effects on cleavage of an endog-
enous ADAM10 target, the adhesion molecule N-cadherin was
FIGURE 8. The combined cysteine-rich (C) and stalk (S) region of ADAM10 without the disintegrin (D) is sufficient to interact with Tspan14. A,
HEK-293T cells were mock transfected () or transfected with FLAG-tagged human CD9 or Tspan14, with co-transfection of Myc-tagged human
ADAM10, or pDisplay constructs containing ADAM10DCS or ADAM10CS, which also possessedMyc tags. Cells were lysed in 1% digitonin lysis buffer and
immunoprecipitated with an anti-FLAG antibody. Immunoprecipitated proteins were blotted with anti-Myc tag antibody (top panel) or anti-FLAG
antibody (lower panel). Whole cell lysates were probed with the anti-Myc tag antibody (middle panel). B, data in panel A (upper panel) were quantitated
from three experiments. Data were log transformed and compared statistically with a one-way ANOVA with a Dunnett’s multiple comparison test
against the mock. Tspan14 bound significantly to ADAM10DCS (p  0.0001) and ADAM10CS (p  0.0001). A diagrammatic representation of the
ADAM10 constructs is shown below the graph. C, HEK-293T cells were mock transfected () or transfected with FLAG-tagged human CD9 or Tspan14,
with co-transfection of pDisplay ADAM10CS or ADAM10S. Cells were treated as in panel A. D, data in panel C were quantitated from three experiments.
Data were log transformed and compared statistically with a one-way ANOVA with a Dunnett’s multiple comparison test against the mock. Tspan14
bound significantly to ADAM10CS (p  0.0001) and ADAM10S (p  0.001).
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selected due to its expression in HEK-293T cells and because it
appears to be specifically cleaved by ADAM10 (28). Cleavage
was detected using an antibody to the C-terminal cytoplasmic
tail of N-cadherin, by Western blotting lysates of HEK-293T
cells over-expressing one of each of the FLAG-tagged
TspanC8s. Tspan15, but not the other TspanC8s, promoted a
significant increase in the relative amount of the C-terminal
fragment of N-cadherin versus full-length (Figs. 11A, upper
panel, and 11B). This promotion of N-cadherin cleavage by
Tspan15 was likely to bemore substantial than indicated by the
quantitation (Fig. 11B), because only50% of cells were trans-
fected in these experiments, as assessed by flow cytometry of
co-transfected green fluorescent protein (data not shown). This
finding was not a consequence of TspanC8 expression levels,
because anti-FLAG Western blotting demonstrated that
Tspan15 was not themost highly expressed TspanC8 (Fig. 11A,
lower panel). These data suggest a specific role for Tspan15 in
promoting ADAM10 cleavage of N-cadherin.
To determine whether Tspan15 or other TspanC8s might
promote cleavage of an additional substrate, the platelet colla-
gen receptor GPVI was selected as a known substrate of
ADAM10 (4, 5). Since GPVI is not expressed by HEK-293T
cells, they were co-transfected with constructs for GPVI with
a cytoplasmic GFP tag, the GPVI-associated FcR chain and
TspanC8s. Anti-GFP Western blotting showed that expres-
sion of Tspan14 significantly reduced GPVI cleavage, almost
to the same extent as the ADAM10 inhibitor GI254023X
(Fig. 11C). None of the other TspanC8s significantly altered
FIGURE 9. The TspanC8s bind differentially to the disintegrin (D), cysteine-rich (C), and stalk (S) regions of ADAM10. A, HEK-293T cells were mock
transfected () or transfected with FLAG-tagged mouse TspanC8s or CD9, and co-transfected with the pDisplay vector containing HA-tagged human
ADAM10DCS. Cell lysateswere produced in 1%digitonin lysis buffer and immunoprecipitatedwith an anti-FLAGantibody. Immunoprecipitatedproteinswere
blottedwithanti-HA tagantibody (toppanel) or anti-FLAGantibody (lower panel).Whole cell lysateswereprobedwith theanti-Myc tagantibody (middle panel).
B, data from panel A (upper panel) were quantitated and presented as the amount of immunoprecipitated ADAM10DCS relative to the Tspan14 immunopre-
cipitation, which was arbitrarily set to 100. Data were normalized by log transformation and statistically analyzed using a one-way ANOVA with a Dunnett’s
multiple comparison test comparedwith the CD9 control. All TspanC8s bound significantly to ADAM10DCS (p 0.001). Error bars represent the standard error
of themean from three experiments. C andD, these experimentswere carried out as described for panels A and B except usingHA-tagged humanADAM10CS.
All TspanC8sbound significantly toADAM10DCS (p0.0001). E and F, these experimentswere carriedout as forpanels A andBexceptusingHA-taggedhuman
ADAM10S (****, p 0.0001; **, p 0.01; *, p 0.05).
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GPVI cleavage (Fig. 11D). Interestingly, Tspan14 is relatively
highly expressed in the megakaryocyte/platelet lineage (8),
and so may protect GPVI from cleavage in this cell lineage.
Together with our N-cadherin data and that previously
reported for Notch (10), these findings suggest that
ADAM10 substrate specificity may be dictated by the
TspanC8 with which it is associated.
Discussion
TspanC8 tetraspanins were previously shown to interact
with ADAM10 in overexpression systems (8, 10). In this study,
we generated an antibody to Tspan14 as a representative
TspanC8, which we used to demonstrate that Tspan14 inter-
acts with ADAM10 endogenously in human and mouse pri-
mary cells. To identify the ADAM10-interacting region of
Tspan14, we concentrated on the LEL, since this region on
other tetraspanins facilitates many characterized tetraspanin-
partner protein interactions and is themost divergent region of
tetraspanins, making this a likely partner protein binding sur-
face (29–31). Using chimeras of Tspan14 and CD9, we demon-
strated that the LEL of the tetraspanin mediates its interaction
with ADAM10. The variable region of this LEL was also critical
but not sufficient. The CD9-Tspan14 LEL chimera did not co-
immunoprecipitate ADAM10 to the same level or increase cell
surface expression as much as wild-type Tspan14. This differ-
ence may be due to insufficient stabilization of the LEL of
Tspan14 by the small extracellular loop (SEL) of CD9 in the
chimera. The SEL of Tspan14 is predicted to be just 19 amino
acids compared with 24 amino acids for CD9, with no sequence
homology between them, and it has been hypothesized that the
SEL interacts with the hydrophobic interface of the LEL N-ter-
minal linker (32).Nevertheless, our demonstration that the LEL
of Tspan14 was important for its interaction with ADAM10 is
analogous to similar data for other tetraspanin-partner protein
interactions. The interaction of CD151 with 31 integrins has
been extensively studied using a similar chimeric tetraspanin
approach, demonstrating that the variable region of the LEL is
required for 31 integrin binding, and antibodies that target
the LEL also disrupt the interaction (33–35). Association of
another tetraspanin, CD81, with its partner protein CD19 is
also mediated by the LEL region (36). In addition, CD81 facili-
tates CD19 surface expression and exit from the endoplasmic
reticulum (37), similar to the regulation of ADAM10 matu-
ration and surface expression by the TspanC8s (8–10). How-
ever, for CD19 this also requires transmembrane domain 1 of
CD81 (36). For EWI-2 binding to the related tetraspanins
CD9 and CD81, the CD81 LEL and transmembrane domains
3 and 4 are required, but for CD9 the LEL and transmem-
brane domains 2 and 3 are required (38). A CD82-CD81 LEL
chimera is not sufficient for binding to EWI-2 (38), yet the
LEL of CD9 is able to facilitate binding to EWI-2 (39),
although it is substantially reduced, similar to that observed
for our CD9-Tspan14 LEL chimera binding to ADAM10. It is
therefore possible that a chimera containing additional
transmembrane regions of Tspan14 may increase binding to
wild-type Tspan14 levels.
Despite over 40 known substrates for ADAM10, very few
proteins have been shown to directly interact, biochemically,
with ADAM10. The TspanC8s are the only proteins known to
alter ADAM10 maturation and intracellular trafficking. Using
chimeras of ADAM10 and ADAM17, we have discovered that
the membrane-proximal regions of ADAM10, including the
stalk, cysteine-rich and disintegrin regions, are required for
TspanC8-ADAM10 interaction. To further isolate the interac-
tion region, we used a series of pDisplay constructs with trun-
cation of the extracellular region of ADAM10. Strikingly, the 26
amino acid stalk region of ADAM10 was sufficient for interac-
tion with Tspan15, and this was not increased by inclusion of
cysteine-rich and disintegrin domains. Tspan10, Tspan14, and
Tspan17 each interacted relatively weakly to the stalk region,
while Tspan5 and Tspan33 did not interact at all. Each of these
five TspanC8s exhibited substantial interactions with the stalk
plus cysteine-rich region of ADAM10. These interactions were
not enhanced by the additional inclusion of the disintegrin
domain and, for Tspan17, the interaction was partially
impaired. These data suggest that different TspanC8s engage
ADAM10 in subtly differentways,whichmayhave implications
for ADAM10 function. In particular, ADAM10 may have mul-
tiple conformations that are stabilized by different TspanC8s.
Dornier et al. previously demonstrated that ADAM10-medi-
ated activation of a Notch reporter is promoted by Tspan5 and
Tspan14 expression, but not by Tspan15 (10). We have now
demonstrated that Tspan15, but not the other TspanC8s, pro-
FIGURE 10. Evidence that different TspanC8s interact with ADAM10 by
distinct mechanisms. A, comparison of TspanC8 co-immunoprecipita-
tions with ADAM10 truncation constructs. Quantitation of the co-immu-
noprecipitations of ADAM10DCS, ADAM10CS, and ADAM10S with each
tetraspanin from Fig. 9 were compared. Values were normalized using
Tspan14 data from Fig. 8. All data were relative to the co-immunoprecipi-
tation of ADAM10DCS with Tspan14, which was arbitrarily set to 100. Data
were log transformed and statistical analysis was performed using a one-
way ANOVA with a Dunnett’s multiple comparison test comparing
ADAM10CS (#, p 0.01) or ADAM10S (*, p 0.01) to the ADAM10DCS for
each tetraspanin. Error bars represent the standard error of themean from
three experiments. B, schematic of the potential differential modes of
interaction of the TspanC8s with ADAM10. Bold regions of ADAM10 repre-
sent those required for a strong interaction with the corresponding
TspanC8. Note that Tspan15 has 3 N-linked glycosylation sites and
Tspan17 has 2, whereas Tspan5, 10, 14, and 33 have 3, 0, 1, and 2, respec-
tively; for the latter, Tspan14 is depicted as an example.
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motes ADAM10-mediated N-cadherin cleavage, and that
Tspan14 reduces GPVI cleavage. We propose that different
TspanC8s might direct substrate specificity by constraining
ADAM10 into defined conformations (Fig. 10B), and that the
distinct Tspan15-ADAM10 interaction mechanism may favor
cleavage of certain substrates such as N-cadherin, but may pre-
vent cleavage of others such as Notch. An alternative, and cur-
rently unexplored, possibility is that TspanC8s could regulate
ADAM10 substrate selectivity by directly binding to the
substrates.
We have previously shown Tspan14 to be the most highly
expressed TspanC8 in mouse megakaryocytes at the mRNA
level (8). In the present study, we have used our new Tspan14
antibody to confirm Tspan14 protein expression in mouse and
human platelets, and to demonstrate an association with
ADAM10 in these cells. The best characterized ADAM10 sub-
strate on platelets is the collagen receptor GPVI, which is
emerging as a promising anti-platelet drug target for the treat-
ment of arterial thrombosis (40). Interestingly, GPVI can be
rapidly shed from the platelet surface following platelet activa-
tion, but is protected from ADAM10-mediated cleavage by an
undefined mechanism (4, 5). Since we have shown that
Tspan14 significantly reduces GPVI cleavage in a cell line
model, it is possible that Tspan14 functions as the GPVI pro-
tector on resting platelets.
ADAM10 has both disease-promoting and disease-inhibit-
ing activities, depending on the disease. Inhibition of ADAM10
activity could be beneficial for several diseases, in particular
cancer, inflammatory diseases, asthma, and skin disorders (1).
In contrast, promotion of ADAM10 activity on neurons could
alleviate Alzheimer disease by preventing the generation of
pathogenic -amyloid peptides (1), and on platelets could pre-
vent heart attack and stroke caused by thrombosis, through
collagen receptor GPVI shedding (4, 5). Our data suggest that a
future therapeutic strategy could be to target the LEL of a spe-
cific TspanC8 to disrupt its interaction with ADAM10. This
could lead to ADAM10 activation, or inactivation, or internal-
ization and degradation, and further research is required to
investigate such possibilities. Nevertheless, such a therapeutic
approach might modulate ADAM10 activity toward only cer-
tain substrates, and without the toxic side effects of targeting
ADAM10 on every cell type in the body.
FIGURE11.Differential effectsofTspanC8sonADAM10substrate cleavage:Tspan15promotes cleavageofN-cadherinandTspan14 reduces cleavage
ofGPVI.A, HEK-293T cellsweremock transfected () or transfectedwith FLAG-taggedmouseTspanC8s. The cellswere lysed in1%TritonX-100 lysis buffer and
subjected toWestern blotting with an antibody to the C-terminal cytoplasmic tail of N-cadherin (upper panel) or with an antibody to the FLAG epitope (lower
panel).B, data fromA (upper panel)werequantitatedand the lower, cleavedbandgivenas apercentageof the total (upper and lower band combined). Datawere
normalized by log transformation and statistically analyzed using a one-way ANOVA with a Dunnett’s multiple comparison test compared with the mock
control. Error bars represent the standard error of themean from three experiments (*, p 0.05).C, HEK-293T cellswere co-transfectedwithGPVI and FcR and
one of each of the FLAG-tagged mouse TspanC8s or without a tetraspanin () or with the addition of the ADAM10 inhibitor GI254023X at 10 M. Cells were
treated as in panel A, except lysates were subjected to an anti-GFP antibody (upper panel) instead of an anti-N-cadherin antibody. D, data from panel C (upper
panel) were quantitated as described in panel A (***, p 0.001).
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